<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03180814</url>
  </required_header>
  <id_info>
    <org_study_id>WBV on autonomic function</org_study_id>
    <nct_id>NCT03180814</nct_id>
  </id_info>
  <brief_title>Effects of Whole Body Vibration on Autonomic Function in Healthy Young and Elderly</brief_title>
  <official_title>Acute Effects of Whole Body Vibration on Autonomic Function in Healthy Young and Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Pernambuco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal de Pernambuco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aging causes anatomical and physiological changes in the cardiovascular system and autonomic
      function with decline in its maximum function. This study aimed to evaluate the acute effects
      of whole body vibration on cardiovascular system, autonomic function and heart variability in
      healthy young and elderly. The investigators' hypothesis is that whole body vibration has
      different effects in young and elderly.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 31, 2017</start_date>
  <completion_date type="Actual">December 30, 2017</completion_date>
  <primary_completion_date type="Actual">August 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Autonomic Function</measure>
    <time_frame>Change from Baseline Heart rate variability at 5, 10, 15, 20 and 35 minutes</time_frame>
    <description>Heart rate variability will be assessed from 3-channel holter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sympathetic modulation</measure>
    <time_frame>Change from Baseline Sympathetic modulation at 5, 10, 15, 20 and 35 minutes</time_frame>
    <description>Sympathetic modulation will be assessed from 3-channel holter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parasympathetic modulation</measure>
    <time_frame>Change from Baseline Parasympathetic modulation at 5, 10, 15, 20 and 35 minutes</time_frame>
    <description>Parasympathetic modulation will be assessed from 3-channel holter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sympathovagal Balance</measure>
    <time_frame>Change from Baseline Sympathovagal balance at 5, 10, 15, 20 and 35 minutes</time_frame>
    <description>Sympathovagal Balance will be assessed from 3-channel holter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Change from Baseline Heart Rate at 5, 10, 15, 20 and 35 minutes</time_frame>
    <description>Non-invasive measures will be assessed from 3-channel holter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Change from Baseline Blood pressure at 5, 10, 15, 20 and 35 minutes</time_frame>
    <description>Non-invasive measures of brachial blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral oxygen saturation</measure>
    <time_frame>Change from Baseline Peripheral oxygen saturation at 5, 10, 15, 20 and 35 minutes</time_frame>
    <description>Non-invasive measures will be assessed from pulse oximeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>Change from Baseline at 20 minutes</time_frame>
    <description>Adverse effects reported by volunteers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Healthy</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Young Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy young of both sexes between the ages of 18 and 30 years will perform a whole body vibration session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Elderly Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy elderly of both sexes between the ages of 60 and 80 years will perform a whole body vibration session</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole Body Vibration</intervention_name>
    <description>A whole body vibration session will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz. The amplitude used will be 04 mm.</description>
    <arm_group_label>Young Group</arm_group_label>
    <arm_group_label>Elderly Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elderly individuals aged between 60 and 80 years

          -  Young individuals aged between 18 and 30 years

          -  Able to walk without assistance

          -  Good understanding to perform the proposed procedures

          -  Sedentary or low active

        Exclusion Criteria:

          -  Body Mass Index (BMI) &gt; 35Kg/m2

          -  Systolic blood pressure &gt; 140 mmHg or diastolic blood pressure &gt; 90 mmHg (at rest)

          -  Difficulty adapting to the whole body vibration

          -  Smoking

          -  Neuromuscular or degenerative disorders

          -  Neurological diseases

          -  Cardiopulmonary comorbidities

          -  Cardiac arrhythmias

          -  Osteoarticular disorders

          -  Use of hormone replacement therapy

          -  Use medications or supplements known to affect cardiovascular parameters

          -  Labyrinthitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federal University of Pernambuco</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>December 29, 2017</last_update_submitted>
  <last_update_submitted_qc>December 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Pernambuco</investigator_affiliation>
    <investigator_full_name>Helga Cec√≠lia Muniz de Souza</investigator_full_name>
    <investigator_title>Msc</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

